Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetology & Metabolic Syndrome
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

Morinda citrifolia l. treatments (noni) reduce glycemia in the model of aloxan-induced diabetes in rats

Authors: José Bégue Moreira de Carvalho, Glauce Socorro Barros Viana, José Galberto Martins da Costa, Thyciara Fontenele Marques, Alisson Cordeiro Moreira, Úrsula Tavares de Sousa, João Victor Rodrigues Lacerda, Enaide Soares Santos, Ítalo Cordeiro Moreira, Maria Janice Pereira Lopes, Maria Neyrilane Torquato de Souza

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Diabetes mellitus is a chronic disease characterized by hyperglycemia which Results from alterations in secretion or insulin action. There is a large number of studies searching for natural products potentially hypoglycemic and presenting a low risk of adverse effects. …
Metadata
Title
Morinda citrifolia l. treatments (noni) reduce glycemia in the model of aloxan-induced diabetes in rats
Authors
José Bégue Moreira de Carvalho
Glauce Socorro Barros Viana
José Galberto Martins da Costa
Thyciara Fontenele Marques
Alisson Cordeiro Moreira
Úrsula Tavares de Sousa
João Victor Rodrigues Lacerda
Enaide Soares Santos
Ítalo Cordeiro Moreira
Maria Janice Pereira Lopes
Maria Neyrilane Torquato de Souza
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A45

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue

Meeting abstract

Assistive technologies for diabetes care: a personalized software for progressive foot and ankle home exercises

Meeting abstract

Cardiovascular risk factors in patients with premature myocardial infarction and in their first-degree relatives

Meeting abstract

Nutritional intervention in patients with hypopituitarism secondary to pituitary adenomas with metabolic syndrome

Meeting abstract

The interrelationship between metabolic memory, glycemic variability, oxidative stress and microalbuminuria in type 1 diabetes

Meeting abstract

Gain weight and sleep desynchronization in workers of a tertiary hospital

Meeting abstract

Chronicity, self care, social and family support: how the patient has?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits